Passage 1 (Questions 1-4) Human immunodeficiency virus 1 (HIV-1) protease inhibitors have been successful at lowering HIV-1 levels and blocking the onset of acquired immune deficiency syndrome (AIDS). However, because HIV-1 mutants are developing resistance to current protease inhibitors, new inhibitors such as Compound 1 (molar mass: 483.5 g-mol-¹) are being tested. N Compound 1 Compound 1 has been shown to inhibit HIV-1 protease with K₁ = 60.3 μM (Table 1). K; is the dissociation constant for the enzyme-bound inhibitor, which is either El or ESI, depending on the type of inhibitor. The peptide substrate for HIV-1 protease is IRKILFLDG. HIV-1 protease hydrolyzes only the peptide bond after leucine and before phenylalanine. Compound 1 (μm) 0 60.0 120 Table 1 Kinetic Parameters of HIV-1 Protease with and without Compound 1 N H Км Ксач Км K₁ (mM) (S¹) (mM-¹ s¹) (HM) 1.678 0.250 00.149 0.832 0.126 0.151 60.3 0.430 0.064 0.149 60.3 Note: HIV-1 protease follows Michaelis-Menten kinetics. N N= N A Lineweaver-Burk plot of V.¹ versus [S]-1, both without Compound 1 and with different concentrations of Compound 1, generates a set of parallel straight lines with positive slopes. Adapted from T. Sperka, J. Pitlik, P. Bagossi, and J. Tösner, Bioorganic & Medicinal Chemistry Letters. ©2005 Elsevier Inc. Question 2 If only [1] is increased, then [ESI] or [E] increases. This is an example of: O A. the Bose-Einstein Principle. OB. the Heisenberg Uncertainty Principle. O c. the Le Châtelier's Principle. OD. the Pauli Exclusion Principle. OA. 33.5 and 15.7 Question 3 Which structural change to Compound 1 would make it more water soluble? OB. 75 and 30.1 O C. 150 and 60.3 O A. Replacing benzene CH with N in the ring OB. Replacing C=0 with C=CH₂ OC. Replacing N-N-N with CH-CH=CH OD. Replacing NH with NCH3 O D. 300 and 120.6 Question 4 In μM-s¹ and μM, what should the approximate values of kcat/KM and K, be, respectively, when [1] = 180 μM?
Passage 1 (Questions 1-4) Human immunodeficiency virus 1 (HIV-1) protease inhibitors have been successful at lowering HIV-1 levels and blocking the onset of acquired immune deficiency syndrome (AIDS). However, because HIV-1 mutants are developing resistance to current protease inhibitors, new inhibitors such as Compound 1 (molar mass: 483.5 g-mol-¹) are being tested. N Compound 1 Compound 1 has been shown to inhibit HIV-1 protease with K₁ = 60.3 μM (Table 1). K; is the dissociation constant for the enzyme-bound inhibitor, which is either El or ESI, depending on the type of inhibitor. The peptide substrate for HIV-1 protease is IRKILFLDG. HIV-1 protease hydrolyzes only the peptide bond after leucine and before phenylalanine. Compound 1 (μm) 0 60.0 120 Table 1 Kinetic Parameters of HIV-1 Protease with and without Compound 1 N H Км Ксач Км K₁ (mM) (S¹) (mM-¹ s¹) (HM) 1.678 0.250 00.149 0.832 0.126 0.151 60.3 0.430 0.064 0.149 60.3 Note: HIV-1 protease follows Michaelis-Menten kinetics. N N= N A Lineweaver-Burk plot of V.¹ versus [S]-1, both without Compound 1 and with different concentrations of Compound 1, generates a set of parallel straight lines with positive slopes. Adapted from T. Sperka, J. Pitlik, P. Bagossi, and J. Tösner, Bioorganic & Medicinal Chemistry Letters. ©2005 Elsevier Inc. Question 2 If only [1] is increased, then [ESI] or [E] increases. This is an example of: O A. the Bose-Einstein Principle. OB. the Heisenberg Uncertainty Principle. O c. the Le Châtelier's Principle. OD. the Pauli Exclusion Principle. OA. 33.5 and 15.7 Question 3 Which structural change to Compound 1 would make it more water soluble? OB. 75 and 30.1 O C. 150 and 60.3 O A. Replacing benzene CH with N in the ring OB. Replacing C=0 with C=CH₂ OC. Replacing N-N-N with CH-CH=CH OD. Replacing NH with NCH3 O D. 300 and 120.6 Question 4 In μM-s¹ and μM, what should the approximate values of kcat/KM and K, be, respectively, when [1] = 180 μM?
Biology 2e
2nd Edition
ISBN:9781947172517
Author:Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:Matthew Douglas, Jung Choi, Mary Ann Clark
Chapter4: Cell Structure
Section: Chapter Questions
Problem 32CTQ: You already know that ribosomes are abundant in red blood cells. In what other cells of the body...
Related questions
Question
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 2 steps
Recommended textbooks for you
Biology 2e
Biology
ISBN:
9781947172517
Author:
Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:
OpenStax
Biology 2e
Biology
ISBN:
9781947172517
Author:
Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:
OpenStax